Results for "consumer data right"
691-700 of 797 results for 'consumer data right'
Queensland's coal and CSG overlapping tenure regime getting a makeover
The Queensland Government has released proposed changes to the legislative framework for regulating overlapping coal and coal seam gas tenure which has been a vexed issue since the emergence of the coal seam gas industry in Queensland The changes principally reflect the industry proposal in the ...
Nucleus – corporate law developments
Welcome to our monthly snapshot of regulatory updates and other developments in corporate law. We know you are busy, so our focus is on capturing key issues. ...
Life insurance industry gets a remuneration Bill, ASIC report and Code of Practice
This is a significant week for the life insurance industry with the re-introduction by the Federal Government of a Bill to reform commissions payable on life insurance policies the release by ASIC of findings of its review of life insurance claims and the launch yesterday by the Financial Services ...
Nucleus – corporate law developments: ASIC leadership changes and other updates
ASIC leadership changes; ASX advises constitution amendments for CHESS replacement, and launches consultation on oil and gas reporting amendments; ACCC teams up with UK and German competition regulators on merger control; Federal Court upholds record diesel emissions penalty ...
Portfolio Holdings Disclosure regulations: key aspects of the revised regime
The long-awaited Portfolio Holdings Disclosure (PHD) regulations were made on 11 November 2021, which will give superannuation trustees certainty about the manner in which portfolio holdings information needs to be disclosed to the public. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Linklaters Insight: Global Fintech Year in Review 2019 and Year to Come 2020
In this report, teams from 16 countries including Australia have summarised legal and commercial developments in the fintech space for 2019 and looked forward in predicting likely themes in 2020. ...
Opportunities for private capital to increase renewables investment, despite the transmission logjam
Amid fears that Australia's ambitious grid buildout is falling behind schedule, how are investors continuing to deploy capital in renewables projects? ...
IP Australia announces changes to fees
IP Australia has announced sweeping changes to the amount and timing of official fees for patents, trade marks, designs and plant breeders' rights, as well as changes to fees and recoverable costs for oppositions. The changes will come into effect 1 October 2024. ...
Nucleus – corporate law developments: FIRB introduces temporary streamlined exemption certificates; ASIC issues guidance on product intervention power; ACCC raises concerns about two digital mergers; and other corporate law developments
Nucleus – corporate law developments: FIRB introduces temporary streamlined exemption certificates; ASIC issues guidance on product intervention power; ACCC raises concerns about two digital mergers; and other corporate law developments ...